CDK12 upregulation and adverse correlation with tumor-associated immune cell infiltrates in prostate cancer.

181Background: Biallelic loss of CDK12 has recently been identified as a novel subtype of prostate cancer (PCa). CDK12 altered PCa associates with elevated neoantigen burden and thus may be suitabl...